302 related articles for article (PubMed ID: 28711751)
1. The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients.
Reddy A; Vidal M; Stephen S; Baumgartner K; Dost S; Nguyen A; Heung Y; Kwan S; Wong A; Pangemanan I; Azhar A; Tayjasanant S; Rodriguez E; Waletich J; Lim KH; Wu J; Liu D; Williams J; Yennurajalingam S; Bruera E
J Pain Symptom Manage; 2017 Sep; 54(3):280-288. PubMed ID: 28711751
[TBL] [Abstract][Full Text] [Related]
2. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain.
Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E
J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675
[TBL] [Abstract][Full Text] [Related]
3. [Opioid switch and change of route of administration in cancer patients treated by morphine].
Michenot N; Rostaing S; Baron L; Faure S; Jovenin N; Hubault P; Delorme T; Collin E; Filbet M; Chvetzoff G; Delorme C; Minello C; Magnet M; Ammar D; Krakowski I; Poulain P
Bull Cancer; 2018 Nov; 105(11):1052-1073. PubMed ID: 30274680
[TBL] [Abstract][Full Text] [Related]
4. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E
Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
7. The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.
Reddy A; Yennurajalingam S; Desai H; Reddy S; de la Cruz M; Wu J; Liu D; Rodriguez EM; Waletich J; Shin SH; Gayle V; Patel P; Dalal S; Vidal M; Tanco K; Arthur J; Tallie K; Williams J; Silvestre J; Bruera E
Oncologist; 2014 Nov; 19(11):1186-93. PubMed ID: 25342316
[TBL] [Abstract][Full Text] [Related]
8. [Differential therapeutic aspects of analgesia with oral sustained-release strong opioids: application intervals, metabolism and immunosuppression].
Güttler K; Sabatowski R
Schmerz; 2008 Oct; 22(5):562, 564-8, 570. PubMed ID: 18483817
[TBL] [Abstract][Full Text] [Related]
9. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
[TBL] [Abstract][Full Text] [Related]
10. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain.
Lasheen W; Walsh D; Mahmoud F; Sarhill N; Rivera N; Davis M; Lagman R; Legrand S
Palliat Med; 2010 Jan; 24(1):9-16. PubMed ID: 19910396
[TBL] [Abstract][Full Text] [Related]
11. Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey.
Reddy A; Sinclair C; Crawford GB; McPherson ML; Mercadante S; Hui D; Haider A; Arthur J; Tanco K; Dalal S; Dev R; Amaram-Davila J; Adile C; Liu D; Schuler U; Jammi S; Shelal Z; Del Fabbro E; Davis M; Bruera E
J Palliat Med; 2022 Oct; 25(10):1557-1562. PubMed ID: 35930252
[No Abstract] [Full Text] [Related]
12. Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in chinese patients with cancer pain: a phase 3, randomized, double-blind, multicenter study.
Yu S; Shen W; Yu L; Hou Y; Han J; Richards HM
J Pain; 2014 Aug; 15(8):835-44. PubMed ID: 24846822
[TBL] [Abstract][Full Text] [Related]
13. [New option in the management of cancer pain in Hungary: short acting oral opioid therapy].
Kullmann T; Sipőcz I; Csikós Á; Pintér T
Orv Hetil; 2015 Jun; 156(25):1003-6. PubMed ID: 26170088
[TBL] [Abstract][Full Text] [Related]
14. Indication of Adequate Transdermal Fentanyl Dose in Opioid Switching From Oral Oxycodone in Patients With Cancer.
Matsumura C; Yamada M; Fujihara S; Chisaki Y; Takahashi K; Yano Y
Am J Hosp Palliat Care; 2016 Mar; 33(2):109-14. PubMed ID: 25324418
[TBL] [Abstract][Full Text] [Related]
15. Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting.
Ginsberg B; Sinatra RS; Adler LJ; Crews JC; Hord AH; Laurito CE; Ashburn MA
Pain Med; 2003 Mar; 4(1):31-8. PubMed ID: 12873276
[TBL] [Abstract][Full Text] [Related]
16. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
17. Patient-Controlled Intravenous Analgesia for Advanced Cancer Patients with Pain: A Retrospective Series Study.
Peng Z; Zhang Y; Guo J; Guo X; Feng Z
Pain Res Manag; 2018; 2018():7323581. PubMed ID: 29849846
[TBL] [Abstract][Full Text] [Related]
18. Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.
Jackson LD; Wortzman R; Chua D; Selby D
J Oncol Pharm Pract; 2021 Jan; 27(1):238-243. PubMed ID: 32501183
[TBL] [Abstract][Full Text] [Related]
19. Opioid Rotation in Cancer Pain Treatment.
Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
[TBL] [Abstract][Full Text] [Related]
20. Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy.
Brogan SE; Sindt JE; Jackman CM; White J; Wilding V; Okifuji A
Anesth Analg; 2020 Apr; 130(4):1035-1044. PubMed ID: 31206429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
